[Yuki Maru Hoshi]

So I've heard from a few people since that their doctors knew of the risks and were adamant for the mothers to NOT take acetaminophen. I've seen plenty of online accounts, but these are people closer to me who have brought it up on their own (during conversation)...

Also, Daily Caller shows a PDF with email exchange with J&J basically saying they were seeing the evidence stack up. That may not prove to be an absolute link, but I wonder if part of the reason they sold off the Tylenol label from under their umbrella was to avoid self-inflicted damage if the risk did start to add up. That way it became another company's problem. It's not like they "need" it in their portfolio... (even if it's like a spin off company, it can still limit liability and the extent of damage)

SCOOP: Tylenol Maker Privately Admitted Evidence Was Getting ‘Heavy’ For Autism Risk In 2018
https://dailycaller.com/2025/09/26/s...n-autism-risk/

And holy crap is this PDF/Image compressed...



Direct PDF link: https://cdn01.dailycaller.com/wp-con...09/184-185.pdf

The DCNF obtained the company documents from the law firm Keller Postman LLC, which brought a class action lawsuit against Kenvue in the Federal District Court for the Southern District of New York.

A decade before Weinstein’s email, in 2008, Johnson & Johnson began receiving queries from consumers and physicians about a possible link, emails show.

“Not much choice but to consider this a safety signal that needs to be evaluated,” J&J Office of Consumer Medical Safety Lead Andre Mann wrote in 2008 after receiving a letter from a physician with concerns.

Leslie Shur, the head of the division of Johnson & Johnson that monitors the side effects of drugs already on the market, received an alert in 2012 about concerns about acetaminophen and autism from a concerned father, with one employee writing “in case this goes to press.”

Concerns about a link between Tylenol and neurological disorders may have reached the C-suite by 2014, according to another email, which references then-Johnson & Johnson CEO Alex Gorski.

The makers of Tylenol have closely tracked a drumbeat of scientific publications finding an association between taking the blockbuster drug in pregnancy and infancy and autism risk, other company documents show. (RELATE Pregnant Influencers Seemingly Try To Own Trump With Tylenol)

A 2018 internal presentation the company labeled “privileged and confidential” acknowledges that observational studies show a “somewhat consistent” association between prenatal exposure to Tylenol and neurodevelopmental disorders. Another presentation slide acknowledges that larger meta-analyses — reviews summarizing multiple scientific studies — found an association, but notes weaknesses of these studies like confounding variables and subjectivity in measuring autistic traits.

“Johnson & Johnson divested its consumer health business years ago, and all rights and liabilities associated with the sale of its over-the-counter products, including Tylenol (acetaminophen), are owned by Kenvue,” a Johnson & Johnson spokesman said in a statement.

Hearings before the Court of Appeals for the Second Circuit in the class action suit against Kenvue will begin Oct. 9. Judge Denise Cote granted summary judgement for Kenvue in September 2023, after tossing the scientific testimony from experts for Keller Postman, citing the “great public health implications” of pregnant women not having the drug.

Ashley Keller, lead attorney for the families with autistic children, argues the judge overstepped and that women should be alerted to the risk.

“We saw this nonsense with COVID on all sorts of things that turned out to be untrue. They said these lies were noble lies. Well, we shouldn’t sugar coat things for pregnant moms,” he said to the DCNF.

The judge also responded to the internal records showing that the company knew about studies showing an autism risk by saying that “candid internal discussion […] is positive corporate behavior.”

Whether it's legitimate or not, there's obviously more risk now for class actions/other legal challenges if their own discovery aka internal communications by prominent players are suggesting there is a link... it's not completely out of question and it's enough to get to damages if they are actively hiding any risks to fetus... that's enough to find fault in some jurisdictions in the US.